Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-02

Clinical Trial Update: Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating cannabidiol for diabetic peripheral neuropathic pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cannabidiol (cannabidiol)

Snippet

Sponsor: Pure Green | Conditions: Diabetic Peripheral Neuropathic Pain | Phase 2 | Status: UNKNOWN